2-mercaptoacetate has been researched along with ljc 10627 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Eto, M; Ishii, Y; Mano, Y; Tateda, K; Yamaguchi, K | 1 |
| Asai, N; Hagihara, M; Kawamoto, Y; Koita, I; Koizumi, Y; Mikamo, H; Miyajima, S; Miyazaki, N; Ohno, T; Sakanashi, D; Suematsu, H; Yamada, A; Yamagishi, Y | 1 |
2 other study(ies) available for 2-mercaptoacetate and ljc 10627
| Article | Year |
|---|---|
In vitro potentiation of carbapenems with ME1071, a novel metallo-beta-lactamase inhibitor, against metallo-beta-lactamase- producing Pseudomonas aeruginosa clinical isolates.
Topics: beta-Lactamase Inhibitors; beta-Lactamases; Carbapenems; Enzyme Inhibitors; Microbial Sensitivity Tests; Molecular Structure; Pseudomonas aeruginosa | 2010 |
Effect of sodium mercaptoacetic acid on different antimicrobial disks in the sodium mercaptoacetic acid double disk synergy test for detection of IMP-1 metallo-β-lactamase-producing Pseudomonas aeruginosa isolates in Japan.
Topics: Anti-Bacterial Agents; beta-Lactamases; Ceftazidime; Drug Resistance, Multiple, Bacterial; Drug Synergism; Humans; Japan; Pseudomonas aeruginosa; Sensitivity and Specificity; Thienamycins; Thioglycolates | 2019 |